Investor mix
6 investors on record; lead investors include Kudos Ventures, SU Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Other / undisclosed | 2 | 33% |
Developer of immunotherapies for cancer treatment
6 investors on record; lead investors include Kudos Ventures, SU Investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 67% |
| Other / undisclosed | 2 | 33% |